NewslettersCancer Stem Cell NewsIntestinal Cell NewsCRISPR Screens Identify Cholesterol Biosynthesis as a Therapeutic Target on Stemness and Drug Resistance of Colon CancerBy Justin.choi - October 7, 20210113To identify genetic vulnerabilities of colon cancer, investigators performed targeted CRISPR dropout screens comprising 657 Drugbank targets and 317 epigenetic regulators on two patient-derived colon cancer stem cells-enriched spheroids.[Oncogene] 7992332 {7992332:CCCCCCCC} apa 50 1 167579 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article